Key highlights Retatrutide is a peptide weight loss medication with triple agonism at GLP-1, GIP, and glucagon receptors
This may happen because the CNS (which regulates sleep and waking brain activity) is still maturing
Ethics declarations Conflict of interest The authors declare no competing interests
Several Substances Get Placed on the Category 2 Bulks List The following substances were added to Category 2 because FDA claimed to identify significant safety risks: AOD 9604 BPC-157 Cathelicidin LL-37 CJC-1295 Dihexa Acetate Emideltide (DSIP) Epitalon GHK-Cu (for injectable routes of administration) Ibutamoren Mesylate Ipamorelin Acetate Kisspeptin-10 KPV Melanotan II Mechano Growth Factor, Pegylated (PEG-MGF) MOTs-C Selank Acetate (TP-7) Semax (heptapeptide) Thymosin Alpha-1 (Ta1) Thymosin Beta-4, Fragment (LKKTETQ) Compounding Industry Group Initial Response In early October, Scott Brunner from the Alliance for Pharmacy Compounding (APC) commented on the updates, particularly noting the addition of certain peptides to Category 2
Similarly, the phytochemical carvacrol induces neurite outgrowth by activating the TrkA receptor and its downstream pathways independently of NGF (Sisti et al., 2021)
Key Benefits Promotes liver health and detoxification Offers a bioavailable form of glutathione Produced in an FDA-registered facility following cGMP guidelines Non-GMO and free from artificial additives 9
